Tejada, Princisso, Jr. O.
HRN: 20-24-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/25/2022
06/01/2022
IV
500mg
Q8h
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes